Flutemetamol F 18

CHEMBL2042122 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

273.3 g/mol

LogP

3.8

Phase

4

This is the fluorine-18 radiolabeled form of flutemetamol used as a PET radiotracer to image amyloid plaques.

Masse moléculaire

273,3200 g/mol

LogP

3,80

TPSA

73,40 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Alzheimer's Disease Breast Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CNc1ccc(-c2nc3ccc(O)cc3s2)cc1[18F]

InChI

InChI=1S/C14H11FN2OS/c1-16-11-4-2-8(6-10(11)15)14-17-12-5-3-9(18)7-13(12)19-14/h2-7,16,18H,1H3/i15-1

Molecular Formula

C14H11FN2OS

HBD / HBA

2 / 5

Liaisons Rotatives

2

Atomes Lourds

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This is the fluorine-18 radiolabeled form of flutemetamol used as a PET radiotracer to image amyloid plaques.

Yes, Flutemetamol F 18 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2042122. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 15950376. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Flutemetamol F 18 sur PillFYI

Structure

Données Clés

Formule: C14H11FN2OS

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.